Maintenance nifedipine tocolysis compared with placebo: A randomized controlled trial

Obstetrics and Gynecology

Volumn 112, Issue 6, 2008, Pages 1221-1226

  Lyell, Deirdre J ^a,b   Pullen, Kristin M ^c   Mannan, Jana ^c   Chitkara, Usha ^c   Druzin, Maurice L ^c   Caughey, Aaron B ^c   El Sayed, Yasser Y ^c  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; MAGNESIUM SULFATE; NIFEDIPINE; PLACEBO; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; BIRTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; LUNG EDEMA; MAINTENANCE THERAPY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TOCOLYSIS; UTERINE CERVIX DILATATION; UTERUS CONTRACTION; DRUG ADMINISTRATION; KAPLAN MEIER METHOD; PREMATURITY; RISK; TREATMENT OUTCOME;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; ODDS RATIO; PREGNANCY; PREMATURE BIRTH; TOCOLYTIC AGENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58849093670     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31818d8386     Document Type: Article

References (24)

1. Soloff MS, Jeng YJ, Copland JA, Strakova Z, Hoare S. Signal pathways mediating oxytocin stimulation of prostaglandin synthesis in select target cells. Exp Physiol 2000;85 Spec No:51S-58S.
2. Nayler WG, Poole-Wilson P. Calcium antagonists: definition and mode of action. Basic Res Cardiol 1981;76:1-15.
3. Papatsonis DN, Lok CA, Bos JM, Geijn HP, Dekker GA. Calcium channel blockers in the management of preterm labour and hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol 2001;97:122-40.
4. Carr DB, Clark AL, Kernek K, Spinnato JA. Maintenance oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol 1999;181:822-7.
5. Sayin NC, Varol FG, Balkanli-Kaplan P, Sayin M. Oral nifedipine maintenance therapy after acute intravenous toco-lysis in preterm labor. J Perinat Med 2004;32:220-4.
6. Gaunekar NN, Crowther CA. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour. The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004071. DOI: 10.1002/14651858.CD004071.
7. Brown SM, Tejani NA. Terbulatine sulfate in the prevention of recurrence of premature labor. Obstet Gynecol 1981;57:22-5.
8. Lewis R, Mercer BM, Salama M, Walsh MA, Sibai BM. Oral terbutaline after parenteral tocolysis: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1996;175: 834-7.
9. Creasy RK, Golbus MS, Laros RK Jr, Parer JT, Roberts JM. Oral ritodrine maintenance in the treatment of preterm labor. Am J Obstet Gynecol 1980;137:212-9.
10. Holleboom CA, Merkus JM, van Elferen LW, Keirse MJ. Double-blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labour. Br J Obstet Gynaecol 1996;103:702-5.
11. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial. Am J Obstet Gynecol 1998;179:874-8.
12. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996;175:838-42.
13. Dodd JM, Crowther CA, Dare MR, Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. The Cochrane Database of Systematic Reviews 2006, Issue 1. Art No.: CD003927. DOI: 10.1002/ 14651858.CD003927.
14. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol 1999;181:484-90.
15. Sanchez-Ramos L, Huddleston JF. The therapeutic value of maintenance tocolysis: an overview of the evidence. Clin Perinatol 2003;30:841-54.
16. Bracero LA, Leikin E, Kirshenbaum N, Tejani N. Comparison of nifedipine and ritodrine for the treatment of preterm labor. Am J Perinatol 1991;8:365-9.
17. Ferguson JE 2nd, Dyson DC, Schutz T, Stevenson DK. A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome. Am J Obstet Gynecol 1990;163:105-11.
18. Lyell DJ, Pullen KP, Campbell L, Ching S, Druzin ML, Chitkara U, et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol 2007;110:61-7.
19. van Veen AJ, Pelinck MJ, van Pampus MG, Erwich JJ. Severe hypotension and fetal death due to tocolysis with nifedipine. BJOG: 2005;112:509-10.
20. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol 1993;100:959-61.
21. Ferguson JE 2nd, Schutz T, Pershe R, Stevenson DK, Blaschke T. Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol 1989;161:1485-90.
22. Fox NS, Gelber SE, Kalish RB, Chasen ST. Contemporary practice patterns and beliefs regarding tocolysis among U.S. Maternal-fetal medicine specialists. Obstet Gynecol 2008;112: 42-7.
23. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, et al. National Vital Statistics Reports. Births: final data for 2005. Available at: http://www.cdc.gov/nchs/data/ nvsr/nvsr56/nvsr56-06.pdf. Retrieved May 30, 2008.
24. ACOG Committee on Practice Bulletins - Obstetrics. ACOG practice bulletin. Management of preterm labor. Number 43, May 2003. Int J Gynaecol Obstet 2003;82:127-35.